EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Intestinal Microbiota and Toll-like Receptor 2 Signaling on α-Synuclein Pathology in Nontransgenic Mice Injected with α-Synuclein Preformed Fibrils

Yukako Koyanagi, Momoe Kassai, Hiroshi Yoneyama

Microorganisms · 05.01.2024 · 12 (1) · 106

DOI: 10.3390/microorganisms12010106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 05.01.2024. Verfasst von Yukako Koyanagi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Microbiology, Department of Microbial Biotechnology, Graduate School of Agricultural Science, Tohoku University, Sendai 980-0845…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Core-to-Core Program (Advanced Research Networks) of the Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal microbiota and Toll-like receptor 2 (TLR2), which can bind lipoteichoic acid produced by microbiota, might contribute to the pathogenesis of Parkinson’s disease (PD), which is characterized by α-synuclein accumulation. Although the contribution of intestinal microbiota and TLR2 to PD pathology was validated in genetic PD models, evidence suggests that the effects of TLR2 signaling on proteinopathy might depend on the presence of a genetic etiology. We examined the impact of intestinal microbiota and TLR2 signaling on α-synuclein pathology in a nontransgenic mouse model of sporadic PD. While an α-synuclein preformed fibrils injection successfully reproduced PD pathology by inducing accumulation of α-synuclein aggregates, microglial activation and increased TLR2 expression in the brains of nontransgenic mice, antibiotic-induced reduction in the density of intestinal microbiota and TLR2 knockout had small impact on these changes. These findings, which are in contrast to those reported in transgenic mice harboring transgene encoding α-synuclein, indicate that the contribution of intestinal microbiota and TLR2 signaling to α-synuclein pathogenesis might be influenced by the presence of a genetic etiology. Additionally, these findings suggest that integrating insights from this experimental model and genetic models would further advance our understanding of the molecular mechanisms underlying sporadic PD.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseaseToll-like receptor 2animal modelintestinal microbiotaα-synuclein

Autor:innen und Institutionen

  • Laboratory of Animal Microbiology, Department of Microbial Biotechnology, Graduate School of Agricultural Science, Tohoku University, Sendai 980-0845, Japan.
  • Sumitomo Pharma Co., Ltd., Osaka 554-0022, Japan.

Förderung

  • Core-to-Core Program (Advanced Research Networks) of the Japan Society for the Promotion of Science

Zitieren

APA

Koyanagi, Y., Kassai, M., & Yoneyama, H. (2024). The Impact of Intestinal Microbiota and Toll-like Receptor 2 Signaling on α-Synuclein Pathology in Nontransgenic Mice Injected with α-Synuclein Preformed Fibrils. Microorganisms, 12(1), 106. https://doi.org/10.3390/microorganisms12010106

Vancouver

Koyanagi Y, Kassai M, Yoneyama H. The Impact of Intestinal Microbiota and Toll-like Receptor 2 Signaling on α-Synuclein Pathology in Nontransgenic Mice Injected with α-Synuclein Preformed Fibrils. Microorganisms. 2024;12(1):106. doi:10.3390/microorganisms12010106

BibTeX
@article{Koyanagi2024,
  author = {Koyanagi, Yukako and Kassai, Momoe and Yoneyama, Hiroshi},
  title = {The Impact of Intestinal Microbiota and Toll-like Receptor 2 Signaling on α-Synuclein Pathology in Nontransgenic Mice Injected with α-Synuclein Preformed Fibrils},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {106},
  doi = {10.3390/microorganisms12010106}
}
Kostenlos starten →